Kazunari Tanabe, Japan Invited Speaker
ABO-incompatible Living Kidney Transplantation

Prof. Rolf Weimer, Germany
Increased risk of acute antibody-mediated rejection despite long-term compromised B cell repopulation after rituximab induction in blood group incompatible living-donor renal transplantation

Dr. MARIBEL MERINO-LÓPEZ, Mexico
Deceased-donor acute kidney injury: Impact on postransplant outcome

Miss Shengbing Li, Netherlands
Cellular responses of donor kidneys during normothermic machine perfusion predict post-transplant outcome

Prof. YUKI NAKAGAWA, Japan
Current status of ABO incompatible kidney transplantation in Japan ― based on statistical data of renal transplantation in Japan

Dr. aviral kashyap, India
A single centre ABO incompatible transplantation experience of 160 patients in North India : Outcomes, protocols and the way forward

Dr. Deepak Shankar Ray, India
Comparison of thymoglobulin and grafalon as induction agents in ABO- incompatible kidney transplantation – A single centre retrospective study

Mr. Darren Lim Zi Yang, Singapore
A retrospective cohort study of ABO-incompatible living kidney donor transplantation before and during the COVID-19 Pandemic

Dr. Kentaro Ide, Japan
Crossmatch-Positive, Highly Sensitized Kidney Transplant Recipients after Desensitization with Rituximab ± Bortezomib

Manuel E. Quirno Costa, Argentina
Playing hide and seek with HLA-DRB3/4/5 data in kidney transplantation reports in Argentina

Prof. Narayan Prasad, India
Impact of HLA Donor Specific Antibody VsNon-Donor Specific Antibodies by Single Antigen Bead method in predicting Outcome of Livingrelated renal allograft recipients